Patients
- Transfer diagnosis
- Training
Information - Clinical therapeutic research
- Research in human science
GIMI Genomic and Immunotherapy Medical Institute
The GIMI was created by Dijon University Hospital Burgundy, Besançon University Regional Hospital, the Centre Georges François Leclerc and the Burgundy and Franche-Comté Blood Bank (Etablissement Français of Sang) in 2016 with the aim to make genomic medicine a clinical reality for patients with cancer, rare diseases and common diseases.
These establishments are organized to federate their resources thus making it possible to:
- respond to the biomedical challenges of genomic medicine,
- make available to other hospital establishments tools to optimize the diagnosis and the management of rare disease and develop treatments in oncology and immuno-oncology,
- propose a platform for diagnosis and translational research implicated in the processing of these data with the aim to promote innovation in the field of biomarkers and of targeted therapies.
Find out more
News
January 3, 2017
The CHU of Dijon, the CHRU of Besançon, the CGFL and the Burgundy Franche-Comté Blood Bank (Etablissement Français de Sang), have signed the convention for the creation of the GIMI Scientific Interest Group, developed in 2016
March 9, 2017
The GIMI submitted the GENOMICARE project for the call for projects for a sequencing platform launched by the DGOS
June 7, 2017
The GIMI Institute gathered its 1st Prospective Committee
September 11, 2017
GIMI Insitute will launch its first cycle of conferences on September 11, 2017, starting at 6 pm in the Salle des événements of the CHU François Mitterrand in Dijon. Dr. Céline Verstuyft (Paris Sud-Hôpital de Bicêtre) will discuss "The place of pharmacogenomic tests in the management of cancer", while Prof. François Ghiringhelli (Dijon-Center GF Leclerc) will present "Pharmacogenetics and colon cancer Metastatics: what evidence? And state of practice at the GF Leclerc Center ".
Genomic medicine consultations in Burgundy Franche-Comté
FHU TRANSLAD and the GAD team
Overall Coordinator:
Pr. Laurence Olivier-Faivre
Deputy Coordinator:
Pr. Christel Thauvin
The Integrated Center for Personalized Medicine in Oncology and the CADIR team
Head:
Pr. François Ghiringhelli
CIC and the TIM-C team
Immuno-Molecular Therapy for Cancers
Head:
Pr. Christophe Borg
RCP molecular oncology
Romain Boidot and Allan Lancon
Oncogenetics Unit
E-mail
Tel:+33 (0)3 80 73 77 08
RCP rare diseases
Élodie Gautier
Coordination Assistant for FHU TRANSLAD
E-mail
Tel:+33 (0)3 80 29 31 25
RCP molecular hemato-oncology
Monique Grandjean
Head of the Hematology Project
E-mail
Tel: +33 (0)3 80 29 50 47